Drug · DIN 02433362
LOSARTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 1, 2017.
- Drug Identification Number (DIN)
- 02433362
- Company (DIN owner)
- Actavis Pharma CompanyToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Losartan C09CA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LOSARTAN POTASSIUM | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 26, 2014: NOC 16364Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named LOSARTAN
- DIN 02388790 · Marketed
- DIN 02388804 · Marketed
- DIN 02388812 · Marketed
- DIN 02388863 · Marketed
- DIN 02388871 · Marketed
- DIN 02388898 · Marketed
- DIN 02394367 · Cancelled Post Market
- DIN 02394375 · Cancelled Post Market
- DIN 02394383 · Cancelled Post Market
- DIN 02399296 · Cancelled Pre Market
- DIN 02399318 · Cancelled Pre Market
- DIN 02399326 · Cancelled Pre Market
- DIN 02410435 · Cancelled Pre Market
- DIN 02410443 · Cancelled Pre Market
- DIN 02410451 · Cancelled Pre Market
- DIN 02433346 · Cancelled Pre Market
- DIN 02433354 · Cancelled Pre Market